Nervonik
PrivateLast Round
Series B
Apr 27, 2026
Est. Valuation
$121M
Total Funding Raised
$74.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nervonik is a therapeutic devices company that develops miniaturized, power-efficient neuromodulation implants and peripheral nerve stimulation (PNS) systems for chronic neuropathic pain.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nervonik Comparables
Compare Nervonik with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neuros Medical | 87% | |
| SPR Therapeutics | 84% | |
| Curonix | 84% |
Nervonik Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 27, 2026 | ||||
| Series A | Mar 4, 2025 |
Nervonik Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amzak Health | Series B |
| U.S. Venture Partners | Series B, Series A |
| Foothill Ventures | Series A, Series B |
| Seraph Group | Convertible Debt, Seed |
| Joyance Partners | Convertible Debt, Seed |
| ShangBay Capital | Convertible Debt, Series B, Seed |
| Lumira Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 13, 2026
Open roles increased to 3, 3x the trailing average.
- Apr 27, 2026
$53M round led by Amzak Health.
Recent news
Latest coverage and updates
- hiresJul 13, 2026
Nervonik, Inc hires Rob.
- is_developingJul 13, 2026
Nervonik, Inc is developing peripheral nerve stimulation platform.
- is_developingJul 13, 2026
Nervonik, Inc is developing minimally invasive peripheral nerve stimulation system designed to treat chronic pain on Jul 13th '26.
- hiresJul 13, 2026
Nervonik, Inc hired Patrick Martin as vice president of clinical affairs on Jul 13th '26.
- hiresJul 13, 2026
Nervonik, Inc hired Rob DiTota as Chief Commercial Officer on Jul 13th '26.
Nervonik Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access